13G Filing: James E. Flynn and Proteon Therapeutics Inc (PRTO)

Page 7 of 19

Page 7 of 19 – SEC Filing

CUSIP No.

74371L109

13G Page 7
of 15 Pages
1.

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Deerfield International Master Fund, L.P.

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)

(b) ☒

3.

SEC USE ONLY

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

British Virgin Islands

 

 

 NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5.

SOLE VOTING POWER

0

6.

SHARED VOTING POWER

110,557

7.

SOLE DISPOSITIVE POWER

0

8.

SHARED DISPOSITIVE POWER

110,557

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

110,557

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0.66%

12.

TYPE OF REPORTING PERSON*

PN

Follow Protara Therapeutics Inc. (NASDAQ:TARA)

Page 7 of 19